US Renal Data System. USRDS 2001 Annual Data Report: Atlas of End-Stage Renal Disease in the United States. Bethesda, Md: The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2001.
2.
US Renal Data System. USRDS 1999 Annual Data Report: Atlas of End-Stage Renal Disease in the United States. Bethesda, Md: The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2001.
3.
Obrador GT, Ruthazer R, Arora P, et al. Prevalence of and factors associated with suboptimal care before initiation of dialysis in the United States. J Am Soc Nephrol. 1999;10:1793-1800.
4.
Holland DC, Lam M.Predictors of hospitalization and death among pre-dialysis patients: a retrospective cohort study. Nephrol Dial Transplant. 2000;15:650-658.
5.
Madore F, Lowrie EG, Brugnara C, et al. Anemia in hemodialysis patients: variables affecting this outcome predictor. J Am Soc Nephrol. 1997;8:1921-1929.
6.
Block GA, Hulbert-Shearon TE, Levin NW, et al. Association of serum phosphorus and calcium × phosphorus product with mortality risk in chronic hemodialysis patients: a national study. Am J Kidney Dis. 1998;31:607-617.
7.
Bostom AG, Shemin D, Verhoef P, et al. Elevated fasting total plasma homocysteine levels and cardiovascular disease outcomes in maintenance dialysis patients: a prospective study. Arterioscler Thromb Vasc Bio. 1997;14(11):2554-2558.
8.
US Department of Health and Human Services. Healthy People 2010: Understanding and Improving Health. 2nd ed.Washington, DC: US Government Printing Office; November 2000.
9.
Hudson JQ, Schonder KS. Advances in anemia management in chronic kidney disease. J Pharm Pract. 2002;15(6):437-455
